Hightide Therapeutics Inc (HK:2511) has released an update.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
HighTide Therapeutics Inc. has announced a strategic collaboration with SSY Group’s subsidiary, Shijiazhuang No. 4 Pharmaceutical, to advance in the fields of metabolic chronic diseases, longevity, and anti-aging. This partnership aims to combine HighTide’s innovative natural product solutions with SSY’s expertise in pharmaceutical development, potentially leading to groundbreaking advancements in these sectors. Investors are advised to stay informed as the collaboration progresses.
For further insights into HK:2511 stock, check out TipRanks’ Stock Analysis page.